Alethia BioTherapeutics' Other Investors

Alethia BioTherapeutics raised a round of funding on , . Investors include Genome Canada.

Alethia BioTherapeutics is a biotechnology company that develops monoclonal antibody therapeutics to clinically relevant targets identified using its STAR discovery technology.…

Articles about Alethia BioTherapeutics' Other Investors: